Roivant Sciences's total assets for Q4 2025 were $5.73B, an increase of 9.62% from the previous quarter. ROIV total liabilities were $435.63M for the fiscal quarter, a 73.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.